#2 - A biomaterial-based vaccine
Episode 2 of the Immunotherapy Talks with ACIR podcast, hosted by Accelerating Cancer Immunotherapy Research (ACIR), titled "#2 - A biomaterial-based vaccine" was published on June 2, 2022 and runs 23 minutes.
June 2, 2022 ·23m · Immunotherapy Talks with ACIR
Summary
Send a text In this 2nd episode, our co-hosts discuss the use of a macro-scale material to co-deliver GMCSF and CpG, both APC stimulating agents, as well as AML antigens to kill AML cells. GUEST: Alex Najibi is now a postdoctoral fellow at Harvard School of Engineering and Applied Sciences, studying bioengineering in David Mooney's lab. Original study => https://pubmed.ncbi.nlm.nih.gov/31937942/ Support the show Thanks for listening! Let’s stay in touch: Tweet us at @ImmunoTal...
Episode Description
In this 2nd episode, our co-hosts discuss the use of a macro-scale material to co-deliver GMCSF and CpG, both APC stimulating agents, as well as AML antigens to kill AML cells.
GUEST: Alex Najibi is now a postdoctoral fellow at Harvard School of Engineering and Applied Sciences, studying bioengineering in David Mooney's lab.
Original study => https://pubmed.ncbi.nlm.nih.gov/31937942/
Thanks for listening! Let’s stay in touch:
- Tweet us at @ImmunoTalks
- Share our episodes on LinkedIN and Instagram
- Email us at [email protected]
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.